Hyperbilirubinämie und transkutane Bilirubinbestimmung

Translated title of the contribution: Hyperbilirubinemia and transcutaneous bilirubinometry

Samar N. El-Beshbishi, Karen Shattuck, Amin A. Mohammad, John R. Petersen

Research output: Contribution to journalArticle

Abstract

Background: Neonatal jaundice or hyperbilirubinemia is a common occurrence in newborns. Although most cases of neonatal jaundice have a benign course, severe hyperbilirubinemia can lead to kernicterus, which is preventable if the hyperbilirubinemia is identified early and treated appropriately. Content: This review discusses neonatal jaundice and the use of transcutaneous bilirubin (TcB) measurements for identification of neonates at risk of severe hyperbilirubinemia. Such a practice requires appropriate serial testing and result interpretation according to risk level from a nomogram that provides bilirubin concentrations specific for the age of the neonate in hours. In this context, we have evaluated the potential impact on clinical outcome and limitations of TcB methods in current use. Summary: TcB measurement is a viable option in screening neonates to determine if they are at risk for clinically significant hyperbilirubinemia. Total serum bilirubin should be measured by a clinical laboratory if a newborn is shown to be at higher risk for clinically significant hyperbilirubinemia. In addition, external quality assessment to identify biases and operator training issues should be part of any TcB monitoring program.

Original languageGerman
Pages (from-to)29-37
Number of pages9
JournalLaboratoriumsMedizin
Volume34
Issue number1
DOIs
StatePublished - Feb 1 2010

Fingerprint

Hyperbilirubinemia
Bilirubin
Neonatal Jaundice
Neonatal Hyperbilirubinemia
Kernicterus
Clinical laboratories
Nomograms
Screening
Monitoring
Testing
Serum

Keywords

  • Bilirubin
  • Icterus neonatorum
  • Kernicterus
  • Neonates
  • Transcutaneous bilirubinometry

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Medical Laboratory Technology

Cite this

Hyperbilirubinämie und transkutane Bilirubinbestimmung. / El-Beshbishi, Samar N.; Shattuck, Karen; Mohammad, Amin A.; Petersen, John R.

In: LaboratoriumsMedizin, Vol. 34, No. 1, 01.02.2010, p. 29-37.

Research output: Contribution to journalArticle

El-Beshbishi, SN, Shattuck, K, Mohammad, AA & Petersen, JR 2010, 'Hyperbilirubinämie und transkutane Bilirubinbestimmung', LaboratoriumsMedizin, vol. 34, no. 1, pp. 29-37. https://doi.org/10.1515/JLM.2010.009
El-Beshbishi, Samar N. ; Shattuck, Karen ; Mohammad, Amin A. ; Petersen, John R. / Hyperbilirubinämie und transkutane Bilirubinbestimmung. In: LaboratoriumsMedizin. 2010 ; Vol. 34, No. 1. pp. 29-37.
@article{1c200b7277fb4b3eacb4818767756f6a,
title = "Hyperbilirubin{\"a}mie und transkutane Bilirubinbestimmung",
abstract = "Background: Neonatal jaundice or hyperbilirubinemia is a common occurrence in newborns. Although most cases of neonatal jaundice have a benign course, severe hyperbilirubinemia can lead to kernicterus, which is preventable if the hyperbilirubinemia is identified early and treated appropriately. Content: This review discusses neonatal jaundice and the use of transcutaneous bilirubin (TcB) measurements for identification of neonates at risk of severe hyperbilirubinemia. Such a practice requires appropriate serial testing and result interpretation according to risk level from a nomogram that provides bilirubin concentrations specific for the age of the neonate in hours. In this context, we have evaluated the potential impact on clinical outcome and limitations of TcB methods in current use. Summary: TcB measurement is a viable option in screening neonates to determine if they are at risk for clinically significant hyperbilirubinemia. Total serum bilirubin should be measured by a clinical laboratory if a newborn is shown to be at higher risk for clinically significant hyperbilirubinemia. In addition, external quality assessment to identify biases and operator training issues should be part of any TcB monitoring program.",
keywords = "Bilirubin, Icterus neonatorum, Kernicterus, Neonates, Transcutaneous bilirubinometry",
author = "El-Beshbishi, {Samar N.} and Karen Shattuck and Mohammad, {Amin A.} and Petersen, {John R.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1515/JLM.2010.009",
language = "German",
volume = "34",
pages = "29--37",
journal = "Laboratoriums Medizin",
issn = "0342-3026",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "1",

}

TY - JOUR

T1 - Hyperbilirubinämie und transkutane Bilirubinbestimmung

AU - El-Beshbishi, Samar N.

AU - Shattuck, Karen

AU - Mohammad, Amin A.

AU - Petersen, John R.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Background: Neonatal jaundice or hyperbilirubinemia is a common occurrence in newborns. Although most cases of neonatal jaundice have a benign course, severe hyperbilirubinemia can lead to kernicterus, which is preventable if the hyperbilirubinemia is identified early and treated appropriately. Content: This review discusses neonatal jaundice and the use of transcutaneous bilirubin (TcB) measurements for identification of neonates at risk of severe hyperbilirubinemia. Such a practice requires appropriate serial testing and result interpretation according to risk level from a nomogram that provides bilirubin concentrations specific for the age of the neonate in hours. In this context, we have evaluated the potential impact on clinical outcome and limitations of TcB methods in current use. Summary: TcB measurement is a viable option in screening neonates to determine if they are at risk for clinically significant hyperbilirubinemia. Total serum bilirubin should be measured by a clinical laboratory if a newborn is shown to be at higher risk for clinically significant hyperbilirubinemia. In addition, external quality assessment to identify biases and operator training issues should be part of any TcB monitoring program.

AB - Background: Neonatal jaundice or hyperbilirubinemia is a common occurrence in newborns. Although most cases of neonatal jaundice have a benign course, severe hyperbilirubinemia can lead to kernicterus, which is preventable if the hyperbilirubinemia is identified early and treated appropriately. Content: This review discusses neonatal jaundice and the use of transcutaneous bilirubin (TcB) measurements for identification of neonates at risk of severe hyperbilirubinemia. Such a practice requires appropriate serial testing and result interpretation according to risk level from a nomogram that provides bilirubin concentrations specific for the age of the neonate in hours. In this context, we have evaluated the potential impact on clinical outcome and limitations of TcB methods in current use. Summary: TcB measurement is a viable option in screening neonates to determine if they are at risk for clinically significant hyperbilirubinemia. Total serum bilirubin should be measured by a clinical laboratory if a newborn is shown to be at higher risk for clinically significant hyperbilirubinemia. In addition, external quality assessment to identify biases and operator training issues should be part of any TcB monitoring program.

KW - Bilirubin

KW - Icterus neonatorum

KW - Kernicterus

KW - Neonates

KW - Transcutaneous bilirubinometry

UR - http://www.scopus.com/inward/record.url?scp=77649282691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649282691&partnerID=8YFLogxK

U2 - 10.1515/JLM.2010.009

DO - 10.1515/JLM.2010.009

M3 - Article

VL - 34

SP - 29

EP - 37

JO - Laboratoriums Medizin

JF - Laboratoriums Medizin

SN - 0342-3026

IS - 1

ER -